BriaCell Therapeutics Corp.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-2.7M | $21.2K |
| FY2021 | — | $27.7M | $57.3M |
| FY2022 | — | $10.3M | $41.0M |
| FY2023 | — | $-3.8M | $21.3M |
| FY2024 | — | $-2.7M | $862.1K |
| FY2025 | — | $17.3M | $10.5M |
| FY2026 | — | $15.6M | $9.9M |